Bionano Genomics, Inc.【BNGO】

Market cap

$3.73M

P/E ratio

	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	17	17	38	25	5	18	9
Investments	-	-	-	226	108	49	0
Accounts receivable, net	5	6	3	5	7	9	5
Inventory	-	-	-	-	-	23	11
Prepaid expenses and other current assets	919,500	1	2	4	7	6	3
Restricted investments	-	-	-	-	-	35	11
Total current assets	23	28	47	272	157	140	39
Restricted cash	-	-	-	-	0	0	0
Property and equipment, net	2	2	5	10	18	23	19
Operating lease right-of-use assets	-	-	-	7	7	6	2
Finance lease right-of-use assets	-	-	-	4	4	4	3
Intangible assets, net	-	-	1	27	41	34	10
Other long-term assets	-	-	102,640	1	2	7	3
Total assets	25	30	60	377	308	214	77
Accounts payable	1	3	3	10	13	10	7
Accrued expenses	3	3	6	10	11	8	6
Contract liabilities	-	-	-	-	-	1	1
Operating lease liability	-	-	-	1	2	2	3
Finance lease liability	-	-	-	0	0	0	0
Purchase option liability (at fair value)	-	-	-	-	-	9	-
Notes Payable, Fair Value Disclosure, Current	-	-	-	-	-	70	20
Total current liabilities	5	26	9	22	36	100	37
Operating Lease, Liability, Noncurrent	-	-	-	5	6	4	0
Finance Lease, Liability, Noncurrent	-	-	-	4	4	4	4
Contingent consideration	-	-	-	-	13	11	-
Long-term contract liabilities	-	-	-	-	-	0	0
Total liabilities	15	27	25	40	58	118	41
Preferred Stock, Value, Issued	-	-	-	-	-	-	-
Common Stock, Value, Issued	1,004	3,427	18,995	0	0	0	-
Additional paid-in capital	83	106	179	554	599	677	729
Accumulated deficit	-72,762,428	-102,577,498	-143,683,849	-216	-349	-581	-693
Accumulated other comprehensive income	-	-	-	-1	-1	0	0
Total stockholders’ equity	10	4	35	337	249	96	35
Total liabilities and stockholders’ equity	25	30	60	377	308	214	77